Relovox
NDC Package 51350-005-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Relovox is indicated and use for the management of acne and removal of the acne spots, Apply on the skin with a gentle massage twice a day, rinse thoroughly with hot water, pat dry with a clean towel.Children under 2 years of age, consult your doctor. Marketed by Transdermal Corp, this product is identified by NDC 51350-005 and is authorized under FDA application part333D.

Identification & Billing

NDC Package Code
51350-005-06
Package Description
1 TUBE in 1 CARTON / 30 g in 1 TUBE (51350-005-05)
Product Code
51350-005
11-Digit Billing Format
51350000506
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Relovox
Dosage Form
-
Usage Information
Indicated and use for the management of acne and removal of the acne spots, Apply on the skin with a gentle massage twice a day, rinse thoroughly with hot water, pat dry with a clean towel.Children under 2 years of age, consult your doctor

Regulatory & Marketing

Labeler Name
Transdermal Corp
FDA Application #
part333D
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
03-31-2011
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51350-005-06 identifies a specific commercial package of 1 tube in 1 carton / 30 g in 1 tube (51350-005-05) of Relovox, labeled by Transdermal Corp. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Transdermal Corp on March 31, 2011. The current certification is valid through December 31, 2017.

How is this Transdermal Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51350000506. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51350-005-06
11-Digit CMS (5-4-2)
51350-0005-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.